Japan Lifeline Co., Ltd.

Equities

7575

JP3754500001

Medical Equipment, Supplies & Distribution

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-04-26 am EDT			5-day change	1st Jan Change
1,161 ^JPY	+1.57%		+1.75%	-8.08%

Mar. 13	Japan Lifeline Completes Cancellation of 7.16 Million Shares	MT
Mar. 01	Tranche Update on Japan Lifeline Co., Ltd.'s Equity Buyback Plan announced on May 10, 2023.	CI

Tranche Update on Japan Lifeline Co., Ltd.'s Equity Buyback Plan announced on May 10, 2023.

March 01, 2024 at 01:10 am EST

From January 1, 2024 to February 29, 2024, the company has repurchased 432,400 shares, representing 0.57% for ¥560.83 million. With this, the company has completed the repurchase of 3,000,000 shares, representing 3.9% for ¥3,319.77 million under the buyback announced on May 10, 2023.

Latest news about Japan Lifeline Co., Ltd.

Japan Lifeline Completes Cancellation of 7.16 Million Shares	Mar. 13	MT
Tranche Update on Japan Lifeline Co., Ltd.'s Equity Buyback Plan announced on May 10, 2023.	Mar. 01	CI
Japan Lifeline Co., Ltd.'s Equity Buyback announced on May 10, 2023, has closed with 3,000,000 shares, representing 3.9% for ¥3,319.77 million.	Feb. 28	CI
Japan Lifeline Co., Ltd. Provides Dividend Guidance for the Year Ending March 31, 2024	Feb. 02	CI
Japan Lifeline Co., Ltd. Announces the Appointment of Nobuo Takahashi as Operating Officer, Associate Executive Manager of CVG Business Unit	Jan. 31	CI
Japanese Shares Return to Green on Upbeat Economic Data	Jan. 05	MT
Japan Lifeline Buys Back Shares Worth Over 217 Million Yen	Jan. 04	MT
Tranche Update on Japan Lifeline Co., Ltd.'s Equity Buyback Plan announced on May 10, 2023.	Jan. 04	CI
Japan Lifeline Buys Back 244,300 Shares for 272.88 Million Yen	Dec. 04	MT
Japan Lifeline Co., Ltd. Announces Management Changes	Dec. 01	CI
Japan Lifeline Raises Forecasts for Fiscal 2024 After Better than Expected First Half	Nov. 07	MT
Japan Lifeline Co., Ltd. Revises Year End Dividend Guidance for the Fiscal Year 2024	Nov. 06	CI
Japan Lifeline Co., Ltd. Revises Consolidated and Non-Consolidated Earnings Guidance for the Fiscal Year Ending 31, 2024	Nov. 06	CI
Japan Lifeline Co., Ltd. Enters into Exclusive Distribution Agreement with Meril Life Sciences Pvt. Ltd	23-10-27	CI
Tranche Update on Japan Lifeline Co., Ltd.'s Equity Buyback Plan announced on May 10, 2023.	23-10-02	CI
Japan Lifeline Completes Disposal of 69,000 Shares for 68.31 Million Yen	23-08-25	MT
Japan Lifeline Launches Open Stent Graft Product	23-08-22	MT
Japan Lifeline Co., Ltd. Announces That It Will Start Selling A New Lineup of Its Proprietary Open Stent Graft Product Frozenix Partial ET from August 2023	23-08-21	CI
Japanese Shares Gain on Upbeat Performance of Manufacturing, Transport, Railway and Bus Sectors	23-08-10	MT
Japan Lifeline to be Included in JPX-Nikkei Mid and Small Cap Index	23-08-10	MT
Japan Lifeline Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending September 30, 2023 and Year Ending March 31, 2024	23-08-02	CI
Japan Lifeline Co., Ltd. Provides Dividend Guidance for the Year Ending March 31, 2024	23-08-02	CI
Tranche Update on Japan Lifeline Co., Ltd.'s Equity Buyback Plan announced on May 10, 2023.	23-07-03	CI
Japan Lifeline Co., Ltd. Enters into Exclusive Distribution Agreement with Haemonetics Japan GK	23-06-28	CI
Japan Lifeline Repurchases Shares Worth 315.5 Million Yen in May	23-06-02	MT

Chart Japan Lifeline Co., Ltd.

Duration

Period

More charts

Company Profile

Japan Lifeline Co., Ltd. is a Japan-based company mainly engaged in the import, manufacture and sale of cardiac circulators and other medical devices. The Company is mainly engaged in the production of rhythm devices, electrophysiological (EP) and ablations, surgical products and intervention products. The rhythm devices include cardiac pacemakers, implantable cardioverter defibrillator (ICD), cardiac resynchronization therapy defibrillator (CRT-D) and other rhythm devices. The EP and ablations include EP catheters for cardiac arrhythmia examination, ablation catheters for arrhythmia treatment and other EP and ablations. The surgical products include prosthetic heart valves and annuloplasty rings for heart disease surgical treatment, vascular grafts, open stent grafts and stent grafts for aortic disease treatment, as well as other surgical products. The intervention products include balloon catheters, guide wires, penetration catheters and other intervention products.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-04-30 - Q4 2023 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Japan Lifeline Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

1,161 JPY

Average target price

1,450 JPY

Spread / Average Target

+24.89%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Devices & Implants

	1st Jan change	Capi.
JAPAN LIFELINE CO., LTD.	-8.08%	553M
STRYKER CORPORATION	+12.07%	128B
SMITH & NEPHEW PLC	-9.04%	10.65B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+0.91%	8.82B
INSPIRE MEDICAL SYSTEMS, INC.	+16.72%	7.19B
GLAUKOS CORPORATION	+25.15%	4.99B
AXONICS, INC.	+7.17%	3.4B
ENOVIS CORPORATION	-1.36%	3.03B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-8.73%	2.14B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-10.15%	2B

Medical Devices & Implants